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review and discuss this paper. I wish you good fortune during the
publication process and look forward to your answers.
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Dr Jeff B. Dattilo (Nashville, Tenn). I’d like to thank the
Society for the privilege of discussing this well written paper. I
appreciate the timeliness with which the authors offered the paper
to me for review. DrMitchell and his esteemed colleagues from the
University of Mississippi have concisely reported their single insti-
tution retrospective data concerning use of TEVAR in the treat-
ment of descending thoracic emergencies. Their data involve three
unique patient populations with three distinct surgical and medical
pathophysiologies: traumatic aortic disruption, rupture of de-
scending thoracic aortic aneurysms, and complicated type B dis-
section. Their results demonstrate improved outcomes with regard
to major morbidity and mortality with use of currently available
commercial aortic devices as compared to historic open controls.
They suggest that this technology can be safely used in all of these
emergent clinical scenarios. Use of this technology required cov-
erage of the subclavian artery in half of the patients with a resultant
paucity of post intervention subclavian artery revascularization,
which is not necessarily dissimilar to many published reports.
I have three questions: With the nearly infectious use of
endoluminal therapy for treating traumatic aortic disruptions,
what are the author’s thoughts on conservative, nonoperative
management of these injuries? Do you use a scoring system of the
intimal or aortic disruption with protocols to determine which
patients to intervene upon acutely?
Second, I noticed in your ruptured descending thoracic aortic
group, you had two individuals well into there 80s die subsequent
to graft placement. You had seven patients in that group. Is your
vascular unit evaluating the advanced-aged patient and there pre-
operative risk to determine if endovascular therapy should be
offered at all in these patients?
Last, I’d like your thoughts on the development of second and
third generation aortic stent grafts particularly designed for the
acutely angled aortic arch, meaning the typical, young patients
most often seen with acute traumatic arch injury. Are we obligated
as a subspecialty to better understand the long-term ramifications
of having these stents in this exceptionally dynamic position for
what could be several decades in these young patients?
Dr Mitchell, it was a pleasure to have the opportunity toDr Marc E. Mitchell. Thank you, Dr Dattilo. We are seeing
ore andmore traumatic aortic disruptions, and I believe there are
wo reasons. Most patients with any significant degree of trauma
ave a CT scan of the chest and CT scan technology has improved
o the point where we are identifying many minor aortic injuries
ow which we never would have picked up in the past. In our
ractice, we probably watch or treat conservatively more aortic
njuries than we operate on. In preparing this manuscript, we
eviewed the CT scans of all the patients we treated and in
etrospect, there was only one patient who probably could have
een treated nonoperatively. The SVS recently published guide-
ines for the treatment of traumatic aortic injuries. They are some-
hat subjective, but we tend to follow those guidelines and do not
perate on patients with minor intimal injuries.
The second question is about elderly patients with ruptured
neurysms. We did not specifically look at patients with reputed
neurysms who we not operated on, but during the study period,
hey were probably as many if not more patients who were treated
xpectantly than were offered surgery. We don’t have a protocol,
ut we look at each patient individually. There are patients with
ittle chance of surviving an operation, but the family still insists on
urgery. Conversely, there are patients in whom we recommend
urgery, but they refuse.
The third question is about new devices. As was made obvious
rom the complication of a graft collapse in a young trauma patient,
here are certainly limitations to the current devices. I have no
oubt that the newer generation of devices will make those com-
lications less common and will improve our ability to treat these
atients.
The question about leaving a stent in a young patient’s aorta
or decades is very interesting. I’m not sure if we will be operating
n these patients in several years and replacing their aortas with
rafts. Even if that is the case, I believe TEVAR in the acute setting
s a better option than doing an open repair in a critically ill patient
ith multisystem trauma. It may turn out that the endovascular
epair is a type of bridge therapy in some patients. The benefits of
EVAR in the face of multisystem traumamake it superior to open
epair and I believe it’s the right thing to do.
